HOSPIRA UK LIMITED

• ⚠

  Material uncertainty over going concern

  The directors have not prepared these financial statements on a going concern basis as they do not believe it is appropriate to do so. This is detailed further in the statement of accounting policies. On 14 December 2018, the company sold its compounded pharmaceutical products business and ceased trading. As the company did not acquire a replacement trade, the directors prepared the 2018, and all subsequent, financial statements on a basis other than going concern. No adjustments were necessary to the amounts at which the assets and liabilities are included in these financial statements.

1. HOSPIRA UK LIMITED 2002-11-28 → present
2. FAULDING PHARMACEUTICALS PLC 1990-02-07 → 2002-11-28
3. F.H. FAULDING (U.K.) LIMITED 1985-07-31 → 1990-02-07
4. HILLMAST LIMITED 1985-06-18 → 1985-07-31

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102 §1A

Reporting scope

Standalone (parent only)

Abridged

Yes — abridged accounts (limited disclosure)

Auditor

KPMG LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“The directors have not prepared these financial statements on a going concern basis as they do not believe it is appropriate to do so. This is detailed further in the statement of accounting policies. On 14 December 2018, the company sold its compounded pharmaceutical products business and ceased trading. As the company did not acquire a replacement trade, the directors prepared the 2018, and all subsequent, financial statements on a basis other than going concern. No adjustments were necessary to the amounts at which the assets and liabilities are included in these financial statements.”

Group structure

1. HOSPIRA UK LIMITED · parent
   1. Hospira Aseptic Services Ltd 100% · United Kingdom · Dormant

Significant events

• “On 14 December 2018, the company sold its compounded pharmaceutical products business and ceased trading.”
• “The company received a dividend from its subsidiary undertaking Hospira Aseptic Services Ltd amounting to £267,056 (2023: £nil). The dividend received has been treated as a return on investment cost for accounting purposes. Hospira Aseptic Services Ltd is currently in liquidation.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

2

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  —

  Not reported

• Cash

  —

  Not reported

• Net assets

  +15.4%

  £117,000 → £135,000

• Employees

  —

  Not reported

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers